top of page
Bsense Bio Therapeutics
Bsense Bio Therapeutics

Efficacious, non-addictive and safe therapeutics
for dampening sensory neuron hyperexcitability

About Us

Bsense Bio

Bsense Bio Therapeutics is developing small molecules for the treatment of sensory hyperexcitability related disorders. We are pioneering a novel approach targeting multiple hyperexcitability related mechanisms using a single compound, to achieve greater efficacy and safety.

TRPV1 (G) Kv7.2 (R) RNAscope in Rat DRG

TRPV1 (G) Kv7.2 (R) RNAscope in Rat DRG

Sensory hyperexcitability

THE UNMET NEED

Sensory hyperexcitability is observed in many different neurological disorders, including Pain, Tinnitus, Pruritus and many more. Sensory hyperexcitability related disorders impact millions of people worldwide.

1 in 10

adults globally is diagnosed with chronic pain each year

$70B

revenue in the global pain management market (in 2022)

75%

of drug overdose death cases are opioid-related

16,500

NSAID-related deaths occur annually in the US among patients with osteoarthritis or rheumatoid arthritis

Demonstrated efficacy in various pain and tinnitus models showcase the potential to treat a wide range of sensory hyperexcitability-related disorders

bottom of page